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Abstract: Fluoride is naturally present in the earth's crust and can be found in rocks, coal, 
and  clay;  thus,  it  can  be  found  in  small  quantities  in  water,  air,  plants,  and  animals. 
Therefore, humans are exposed to fluoride through food, drinking water, and in the air they 
breathe. Flouride is essential to maintain bone strength and to protect against dental decay, 
but if it is absorbed too frequently, it can cause tooth decay, osteoporosis, and damage to 
kidneys, bones, nerves, and muscles. Therefore, the present work was aimed at determining 
the effect of intake of sodium fluoride (NaF) as an apoptosis inducer in leukocytes of rats 
treated for eight weeks with 1 or 50 parts per million (ppm) NaF. Expression of p53, bcl-2, 
and caspade-3 were used as apoptotic and general metabolism indicators of leukocyte-like 
indicators of the (INT) oxidation system. Male rats were exposed to NaF (1 and 500 ppm) 
for eight weeks, and then sacrificed weekly to obtain blood samples. Expression of p53, 
bcl-2,  and  caspase-3  were  determined  in  leukocytes  by  Western  blot,  and  general 
metabolism of leukocytes was analyzed with a commercial kit. We found changes in the 
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expression of the proteins described, especially when the animals received 50 ppm of NaF. 
These results indicate that NaF intoxication can be an apoptosis inducer in rat leukocytes 
treated with the compound for eight weeks.  
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1. Introduction 
Fluoride is a chemical element that is very abundant on the earth’s surface and that is recognized as 
an element that can produce acute and/or chronic changes in humans when they are exposed to it. 
Fluorosis (intoxication by fluoride) is caused by acute or chronic ingestion of fluorides and is clinically 
characterized in humans by dental alterations, as well as alterations in the nervous and musculoskeletal 
systems [1]. 
At the cellular level, experiments conducted in vitro have demonstrated that application of fluoride 
can produce diverse metabolic changes, such as glycolysis inhibition, changes in membrane receptors, 
alteration in total energy balance, DNA breaks, and induction of apoptosis [2–5]. 
In this latter case, it has been postulated that apoptosis induced by an excess of fluoride is produced 
in part by the phenomenon associated with the production of Oxygen-derived free radicals (OFR) that, 
being  highly  reactive  molecules,  can  induce  changes  in  biomolecules  such  as  proteins,  lipids, 
carbohydrates, and nucleic acids [6]. 
It has been described that application of sodium fluoride (NaF) as the main fluoride source to cells 
under culture can induce an excess of p53, a protein expressed when there is damage to the DNA [7]. 
On the other hand, induction of apoptosis has been described in the epithelial cells of human lung 
cultured with growing amounts of NaF, as well as general changes in alveolar macrophages under 
culture [8,9]. Additionally, it has been described that incorporation of fluoride in the diet of animals 
under experimentation can cause liver damage expressed as induction in the expression of caspases 
(that are the last effectors of apoptosis), as well as of the protein bcl-2 (the protein activated during 
apoptosis) [10,11]. 
Conversely, it has been reported that in geographic zones where fluorosis is endemic, there is an 
increase in  the presence of bacterial,  viral,  and parasitic infections  in  humans or in  wild  or farm 
animals that have been intoxicated with this type of compound when it is present in drinking water in 
concentrations exceeding the maximal dose recommended by the World Health Organization (WHO), 
which is <1 parts per million (ppm) of NaF [1,2]. In Mexico, acute and chronic fluorosis is present 
mainly in central-northern states in which the water presents NaF concentrations that exceed WHO 
health norms [1]. The presence of NaF in aquifers is very important because this compound is not 
filtered by the conventional water purification systems that are employed precisely to prepare water for 
human consumption [1–6]. Also, NaF dissolved in water has neither taste nor smell; thus, people can 
ingest great quantities of this toxin without being aware of it [1,6]. Once consumed, NaF can cause 
alterations in systems such as digestive, nervous, reproductive, and immunological [1,12]. 
As  mentioned  previously,  individuals  who  present  fluorosis  are  more  susceptible  to  presenting 
bacterial, viral, and parasitic infections, which indicates that there can be a change in their immune Int. J. Mol. Sci. 2010, 11                       
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system, in which leukocytes play a very important role as defense systems against these infections [1]. 
From  another  viewpoint,  it  is  known  that  leukocytes  in  peripheral  blood  circulation  that  have 
completed  their  useful  life  present  a  natural  process  of  apoptosis  and  are  eliminated  from  the  
organism [1,4,8]. Experiments in vitro have demonstrated that leukocytes incubated in the presence of 
NaF present an increase in the expression of proteins p53 and bcl-2, which are considered markers of 
the presence of apoptosis [1,4–8] and which would indicate that this toxin can promote this type of 
phenomena in systems in vivo. 
The objective of the present work was to describe the effect of NaF on the expression of proteins 
bcl-2, caspase-3, and p53 as indicators of apoptosis in rat leukocytes. 
2. Materials and Methods 
2.1. Chemicals and Animals 
Male  Wistar-strain  rats  (weighing  an  average  of  250  ±   5  g)  were  obtained  from  Laboratorios 
Harlam-Mé xico and placed in individual containers under 12-h light-dark cycles with free access to 
food and water. Male rats were selected because it has been demonstrated that NaF exerts a more 
constant effect, because females present hormone cycles that affect the results [13]. All procedures 
were carried out according to the guidelines contained in the Regulation on Treatment of Animals for 
Surgery and Research of our institution, which is in agreement with the Federal Regulation Law for 
Research and Experimentation Animals (SAGAR, Mexico, 1999). Chemical reagents used were of 
analytical  grade  and  of  the  best  possible  quality.  They  were  obtained  from  Sigma  Chemical  Co.  
(St. Louis, MO, USA), Merck de Mé xico S.A., or from Mallinckrot de Mé xico, S.A. 
2.2. The Treatment Protocol 
The animals were treated according to established protocols in which experimental animals are 
exposed to known concentrations of NaF, which is added to their drinking water [12,14], and changes 
were monitored each week for the time assigned by the protocol. 
The rats were divided randomly into the following study groups: (25 animals per group): 
(a)  Control group: Rats without any treatment that ingested food (Rat Pellet Chow; Purina, Inc., 
MO,  USA)  freely  with  water  from  containers  of  the  liquid  for  human  consumption 
(Electropura-brand drinking bottled water; The Pepsi Bottling Group Mé xico, S. de R.L. de 
C.V.).  According  to  chemical  analyses,  this  water  presented  a  fluoride  concentration  of  
<0.5 ppm; thus, it is considered to  fall within normal  limits and has  been reported as  not 
interfering with the experiment. 
(b)  Experimental group 1: Rats to whose drinking water we had added a concentration of NaF 
equivalent to 1 ppm of fluoride and with free access to food [14]. 
(c)  Experimental  group  50:  Rats  to  whose  drinking  water  we  added  a  concentration  of  NaF 
equivalent to 50 ppm of fluoride and with free access to food [14]. 
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Once the treatment had been initiated, the rats of all groups under study were sacrificed every  
2 weeks (five per group) for up to 8 weeks. During the entire treatment, water was substituted every  
24 h with fresh water, and bromatological data were registered once per week. 
2.3. Obtaining and Processing the Leukocytes 
After anesthesia (ether vapor), the rats were sacrificed by decapitation as previously described [15]. 
Blood was collected in  a recipient with  an anticoagulant (EDTA) and placed in an assay tube as 
previously described [15–17]. Three volumes of histopaque (1077-1; Sigma Chemical Co.) and three 
volumes of whole blood were placed in an adequate tube, and this was centrifuged for 15 min at  
1,500 rpm in a clinical centrifuge (Hermle Z-380, Germany). At the end of centrifugation time, the 
leukocytes that remained in intermediate phase were removed with a Pasteur-type pipette and were 
washed three-times with five volumes of cold phosphate isotonic saline solution (PBS, pH 7), then 
centrifuged  at  1,500 rpm for 10 min., Once they were washed, the leukocytes  were counted  in  a 
hemocytometer and the leukocyte concentration was adjusted to 2 ×  10
6 cells/mL. 
2.4. Determination of the Metabolic Activity of Leukocytes 
Quantitative evaluation of the metabolic activity of the leukocytes as an index of variability was 
performed with a commercial reagent kit (Leucognost®; Hematologie, Merck, Darmstadt, Germany) 
following  the  instruction  guide  provided  by  the  manufacturer,  which  is  based  on  the  procedure 
reported by Lokaj et al. [18]. Briefly, the procedure was as follows: a sample of leukocytes was placed 
together with three volumes of Dulbecco solution with glucose (5 mM) and divided into two parts. One 
of these was incubated in the presence of 1% potato starch, 1% of dimethyl sulfoxide, and 0.1% of 
cloruro  of  3-4-indophenyl-2,4-nitrophenyl-5-phenyl  tetrazolium  (INT;  Sigma  Chemicals).  The 
remaining leukocytes were placed under the same conditions as those of the latter, but without starch. 
Both samples were incubated for 45 min at 37 ° C under constant shaking. At the end of incubation, we 
added two-volumes of absolute methanol and shook this strongly for 3 min. The result was centrifuged 
at 5,000 rpm for 10 min and the supernatant was recovered; was and the absorbance read at 485 nm in 
a spectrophotometer (Jenway 6300; Cielo Vista, CA, USA). The metabolic activity of the leukocytes 
was  expressed  in  nmoles  of  formasan/10
6  cells  according  to  the  procedure  described  in  the  kit’s 
instruction manual. 
2.5. Total Leukocyte Extract 
A sample of leukocytes was diluted with equivalent parts (v/v) of cold lysis buffer (Tris, 0.01 M; 
sucrose, 0.255 M; EGTA, 0.3 mM; pH 7.4 containing protease inhibitors) and was homogenized with a 
sonicator  (Ultra-Turrax  205;  Thompson,  Inc.,  USA)  with  three  2-min  hit  strikes,  each.  The 
homogenate was centrifuged at 10,000 rpm for 20 min. The supernatant was recovered and considered 
as the total leukocyte extract in which we determined the concentration of the total protein by the 
method of Lowry [19] utilizing bovine albumin as standard. Int. J. Mol. Sci. 2010, 11                       
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2.6. Expression of Proteins p-53, bcl-2, and Caspase-3 
Analysis of the presence of apoptosis-indicator proteins in the leukocytes was conducted using the 
techniques of Western blot in acrylamide gels employing the general technique reported by Laemmli 
[20], followed by a nitrocellulose paper blot according to established methods [21]. 
Briefly, we carried out the following: samples of the total leukocyte extract were mixed with an 
equal volume of treatment buffer (2-mercaptoethanol 2 mM; SDS 10%; glycerol 1%; PBS, pH 8) and 
heated in a water bath for 3 min. At the end of incubation, samples of the reaction (100 μg of total 
protein) were placed in 12% acrylamide/0.1% bis-acrylamide-gel wells and submitted to a 150-mV 
current for 80 min in a vertical apparatus for electrophoresis (Bio-Rad, Ltd., Hercules, CA, USA) with 
a running buffer (Tris-base/SDS/glycine). At the end of the run, the gels were placed in an apparatus 
for  electrotransfer  (Bio-Rad,  Ltd.)  employing  a  nitrocellulose  membrane  as  receptor,  and  a  cold 
transfer  buffer  (Tris-base/glycine/methanol/SDS).  Protein  transfer  was  performed  for  80  min  at  
100 mA, at the end of which the nitrocellulose membrane was dyed with a Ponceau red solution to 
determine localization of the proteins. Afterward, the membrane was washed three-times with PBS and 
incubated  for  60  min  at  room  temperature  under  continuous  shaking  in  a  blocking  solution  (5% 
powdered skim milk and 0.5% of Tween-20). At the end of incubation,the membrane was washed three 
times with PBS and was exposed to primary antibody (Santa Cruz, CA, USA) digested against the 
specific protein (p-53, bcl-2, or caspase-3), incubating this under continuous shaking for 70 min and 
with blocking solution. After this incubation, it was washed three times with PBS and exposed for  
60 min to the peroxidase-labeled secondary antibody. The membrane was washed three times with 
PBS and we exposed the presence of the proteins with a solution of hydrogen peroxide (0.5%) and 
tetramethylbenzidine according to the instructions accompanying the commercial kit (Promega, USA) 
that is used for this purpose. Once the protein was localized, the membrane was scanned with Alpha 
Imagen
 TM equipment (V-3.3 1200; USA) with documentation and analysis system to determine, by 
means of absorbance (read at 640 nm), the apparent quantity of each protein per sample [22]. 
2.7. Statistical Analysis 
Data analysis was conducted with the GraphPad Prism ver. 4.00 for Windows (GraphPad Software; 
San Diego, CA, USA) statistical software program with an Excel platform (Microsoft Co.). The results 
are expressed as averages  Standard error (SE) for all study groups. The difference between groups 
was analyzed by two-tailed Analysis of variance (ANOVA), with Tukey post-test when applicable, 
taking a minimum value of p < 0.05 as statistically significant. 
3. Results 
One of the parameters taken into account for evaluating the general effect of a toxin on the integrity 
of a subject-under-study is performance of the determination of body weight during the treatment 
duration [12]. Table 1 depicts the body weight gain in the control group as well as in animals receiving 
1 or 50 ppm of NaF at 8 treatment weeks. As can be observed, none of the NaF doses administered 
demonstrated a significant effect on body weight after 8 weeks of treatment. We also observed no 
significant differences in the amount of water consumed daily by the animals, and solely observed an Int. J. Mol. Sci. 2010, 11                       
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increase in the weekly amount of NaF ingested by the group that received 50 ppm, which is entirely 
logical  because  this  group  consumed  a  greater  concentration  of  the  compounds  in  their  running 
drinking  water.  During  sacrifice  of  the  animals,  these  were  examined  by  a  pathologist  to  denote 
whether  there  was  some  change  in  the  morphology  of  the  animals’  organs  (especially  liver  and 
kidneys), and the result was negative. 
Table 1. Body weight, water consumption, and sodium fluoride (NaF) doses in rats treated 
for up to  8 weeks  with  doses of 1 or 50 parts per million  (ppm) of NaF. Results  are 
expressed as averages  Standard error (SE). 
Treatment 
(n) 
AIW 
(g) 
AFW 
(g) 
WCR 
(mL/day) 
D-NaF 
(mg/kg/week) 
Control (25)  252.13 ±  3.14  314.13 ±  5.39  29.05 ±  0.30  0 
NaF 1ppm (25)  252.70 ±  3.32  312.23 ±  3.32  31.05 ±  0.32  0.868 ±  0.01 
NaF 50 ppm (25)  251.65 ±  4.81  312.12 ±  5.21  30.48 ±  0.27  42.67 ±  0.38 
n:  number  of  rats  per  group;  AIW:  Average  initial  weight;  AFW:  Average  final  weight;  
WCR: Water consumption per rat; D-NaF: Dose of NaF. 
Figure 1 shows a time course of the changes in the metabolic activity of the rat leukocytes treated 
with 1 or 50 ppm of NaF. As can be noted, in comparison with the control group, rats that received the 
1-ppm dose of NaF did not produce significant changes in their metabolic activity. In contrast, the  
50-ppm dose produced a significant decrease (p < 0.05) in this parameter from 2 weeks of treatment 
and the metabolic activity diminished by ca. 20% (p < 0.05) after 8 weeks of treatment (Figure 1). 
Figure 1. Time course of the metabolic activity of leukocytes obtained from the different 
study groups. Each point represents the average ±  Standard error (SE) of five rats per time. 
Asterisks denote a statistical difference (p < 0.05) with regard to the control group. 
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Figures 2–4 depict the time course of the expression of proteins p53, bcl-2, and caspase-3 in the 
leukocytes of rats treated with the two doses of NaF and the determination, by scanning of the Western 
blots, of the relative quantity of protein, as described in the Materials and Methods section. 
As can be noted, the group of rats that received the 50-ppm NaF treatment presented a statistically 
significant increase (p < 0.05) compared with the control group with regard to expression of proteins 
p53 (Figure 2) and caspase-3 (Figure 4) from two weeks of treatment. This increase was maintained 
throughout the eight weeks of the NaF treatment, and it is noteworthy that the 1-ppm dose of NaF 
presented no changes with respect to the controls in the expression of these proteins. 
For its part, the bcl-2 protein exhibits a sustained pattern of expression throughout the treatment 
time in the control group, but it is not this way with the NaF-treated groups, whether with 1- or 50-ppm 
doses (Figure 3). In both groups, we observed an irregular pattern of expression each time that we 
carried out determination of this protein; however, differences in bcl-2 expression for both NaF-treated 
groups  did  not  present  a  statistically  significant  difference  among  these  or  as  compared  with  the 
control group. 
Figure 2. Time course of the expression of the p53 protein on the leukocytes of rats treated 
with 1 or 50 parts per million (ppm) of sodium fluoride (NaF) for up to up 8 weeks.  
(A). From Western blots scanned at 640 nm, the relative amount of protein is expressed in 
absorbance units throughout the treatment time. Each point represents those scanned in 
duplicate of five rats expressed as percentage of control ±  Standard error (SE). Asterisks 
denote p < 0.05 with respect to the control group. (B). a representative image of a Western 
blot of the protein p53. 
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Figure 3. Time course of the expression of the bcl-2 protein on the leukocytes of rats 
treated  with  1  or  50  parts  per  million  (ppm)  of  sodium  fluoride  (NaF)  for  up  to  
8 weeks. (A). Western blots were scanned at 640 nm, and the relative amount of protein is 
expressed in absorbance units throughout the treatment time. Each point represents those 
scanned in duplicate of five rats expressed as percentage of control ±  Standard error (SE). 
(B). a representative image of aWestern blot of the protein bcl-2. 
 
Figure 4. Time course of the expression of the protein caspase-3 on the leukocytes of rats 
treated with 1 or 50 parts per million (ppm) of sodium fluoride (NaF) for up to up 8 weeks. 
(A). Western blots that were scanned at 640 nm, and the relative amount of protein is 
expressed in absorbance units throughout the treatment time. Each point represents those 
scanned in duplicate of five rats expressed as percentage of control ±  Standard error (SE). 
Asterisks denote a p < 0.05 with respect to the control group. (B). a representative image of 
a Western blot of the protein caspase-3. 
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4. Discussion 
Ingestion of NaF incorporated into the drinking water of male rats with 50 ppm of NaF up to  
8 weeks shows that their leukocytes present an important diminution in the expression of proteins p53 
and caspase-3, as shown in Figures 2 and 4. These changes, mainly in the expression of the proteins 
p53 and caspase-3, can be indicative of an increase in apoptosis in this cell type that is induced by the 
presence of NaF, principally in the 50-ppm dose. 
The  data  shown  in  Table  1,  as  well  as  the  clinical  data  observed  in  the  three  study  groups, 
demonstrate that treatment with both doses of NaF (1 and 50 ppm) does not produce the general visible 
alterations  that  have  been  reported  as  potentially  toxic  by  other  researchers  [1,2,12].  On  general 
inspection of the mucosa and teeth of all study groups, we observed no visible signs of fluorosis or any 
type of sign denoting intoxication according to previously established parameters [23,24]. The latter 
finding is in contrast with those of other investigators, who report the initiation of yellow speckling or 
mottle  on  teeth  with  NaF  treatments  ranging  from  5–300  ppm  and  with  a  6–21-week  treatment  
time [1,2,12,25]. It is possible that the treatment time that we employed (8 weeks) is not sufficient for 
producing the visible alterations corresponding to fluorosis, in leukocytes as well as at the general 
level; however, the changes found in metabolic activity, as well as in the expression of proteins p53 
and caspase-3, demonstrate to us that there are metabolic changes in peripheral blood leukocytes that 
are produced by our treatment. While, perhaps, these changes do not translate into visible clinical 
alterations, they do indeed denote a metabolic effect on leukocytes produced by NaF, above all at a  
50-ppm dose. 
Determination of the general metabolic activity of leukocytes has been considered an indicator of 
the normal functioning state of this type of cell [26]. The effect of NaF on the general metabolism of 
leukocytes  has  been  reported  previously  [29];  however,  these  observations  have  derived  from 
experiments conducted in vitro in which the cells have been previously isolated and cultured, which 
renders their interpolation to the entire organism difficult. From another perspective, in experimental 
models with laboratory animals, it has been reported that there is a decrease in the metabolic activity of 
their leukocytes when treatment with NaF lasts at least 10 weeks and up to 300 ppm of NaF in order to 
observe some type of change in this parameter [2,9,10,23–25]. 
This minimal time of observation has been based on the fact of recognizing that NaF-exposed 
animals should reach a degree of clinical intoxication for us to be able to observe metabolic changes 
that can be registered; however, in our treatment model, the animals present an important diminution in 
the  metabolic  activity  of  their  leukocytes  at  two  weeks  of  treatment  with  50-ppm  doses  of  NaF  
(Figure 1). This result could explain that, as mentioned previously, researchers procure that animals 
submitted  to  treatment  with  NaF  present  clinical  or  pathological  signs  of  intoxication  with  this 
compound in order to consider that this element exerts effects on the organism. In this regard, we 
affirm that while animals do not present clinical or pathological signs of intoxication with NaF, they do 
present an alteration in their general metabolic activity, which can indicate metabolic sensitivity of 
leukocytes to this compound without the clinical expression of intoxication by the compound. 
From another point of view, increase in the expression of proteins p53 and caspase-3 in the group of 
rats that received a 50-ppm dose of NaF indicates an increase of apoptosis in the leukocytes, because 
these proteins are considered indicative of an apoptotic process (caspase-3) due to cellular damage 
(protein p53) [11,27–29]. Int. J. Mol. Sci. 2010, 11                       
 
 
3619 
Protein p53 has been described as an indicator of DNA damage that is expressed after exposure to 
radiation or to a toxin [11,27–29]. While it is true that tissue that carries out a continuous replacement 
of cells due to a normal phenomenon of mitosis (as in the case of epithelial and mucosal tissues) 
presents a minimal expression of protein p53, it is also certain that this protein is expressed in excess 
when there is a toxin in the organism that alters genetic expression or damages the DNA [28,29]. 
Conversely, caspase-3 is a protease that degrades the cell’s cytoskeleton during a phenomenon that is 
exclusively  apoptotic  [30,31].  In  this  manner,  leukocytes  are  cells  that  present  a  continuous 
replacement  re-exchange  in  the  circulation  and  that  die  naturally  due  to  an  apoptotic  
phenomenon  [28–31].  Among  effectors  of  apoptosis,  we  find  caspases,  whose  most  important 
representative is caspase-3, in that the latter is one of the main proteases that intervene in programmed 
cell death [29–31]. It has been described that exposure to a toxin can increase caspase expression as a 
reflection of an increase in the apoptosis of this tissue [11,29–31]. Due to what has been previously 
mentioned, we suppose that an increase in p53 and caspase-3 expression in rats exposed to a 50-ppm 
dose of NaF for eight weeks considerably augments the phenomenon of apoptosis in their circulating 
leukocytes. This affirmation is reinforced by the fact that the presence of NaF produces an asynchronic 
pattern of protein bcl-2 expression, as depicted in Figure 3. Protein bcl-2 has been considered an early 
indicator  of  the  cell’s  entrance  into  G1  phase  of  the  cell  cycle,  and  its  expression  presents 
synchronically throughout this phase [29–33]. It has been described that this protein can regulate the 
phenomenon of apoptosis when it is deregulated by a toxin or by exposure of the cells to radiation 
[31]. As illustrated in Figure 3, the presence of NaF at any of the tested doses produces asynchrony in 
bcl-2 expression, which, together with the data obtained for p53 and caspase-3, we can suggest that 
NaF induces an increase in the apoptosis of leukocytes in rat. It is noteworthy that the expression of the 
protein p53 is not in agreement with that of bcl-2 throughout the time of intoxication with NaF, which 
agrees with reports by other researchers, who found the same disparity among the expressions of 
apoptosis-related proteins [31,35]. The reason for this disparity in the expression of these proteins in 
our model of exposure to NaF is not known; therefore, additional studies are required to clarify this 
phenomenon, probably utilizing in vitro studies. 
This increase in apoptosis due to the effect of exposure of the tissues or cells to NaF has been 
reported previously [8–10]; however, to our knowledge, there are no prior reports that describe the 
increase in apoptosis in circulating leukocytes in models in vivo. 
The effect of NaF on circulating blood leukocytes that we have observed in this study gives us 
cause to suppose that this chemical compound can act as a toxic agent for these cells to the degree of 
inducing the process of apoptosis in them. This is of fundamental importance, because, as has been 
reported previously, in geographic zones where there is a high content of this toxin in the water, there 
is an increase of infectious diseases in animals as well as in humans, which makes us think that this 
compound causes important damage to the immune system [33,34]. 
Conversely, it is known that NaF is a compound that is widely utilized as an anticaries agent added 
to  popular  pastes  and  gels  for  dental  hygiene  in  concentrations  that  can  be  as  high  as  
1,500 ppm [14,34]. Although under normal conditions of use, toothpastes that contain NaF have only a 
brief time of contact with the organism (the time it takes to brush the teeth), it has been reported that 
children who are learning to brush their teeth and use fluorinated toothpastes tend to swallow this type Int. J. Mol. Sci. 2010, 11                       
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of  compound,  which  may  provoke  acute  or  chronic  fluorosis,  in  addition  to  other  metabolic  
problems [14,34]. 
5. Conclusion 
According to the results obtained, we suggest that exposure of rats to NaF modifies the expression 
of p53, bcl-2, and caspase-3 and causes general metabolic changes toleukocytes, which are indicators 
of changes to normal pattern of apoptosis. 
It is clear that additional investigations are required to evaluate more precisely the effects that NaF 
can exert in this type of cell; however, we are able to state that our study model can be useful for 
investigating in a more detailed fashion the effect of this toxin on leukocytes and on other cell and 
tissue types. 
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